Mary M. Rozenman, See Remarks at Aimmune Therapeutics, Inc. (AIMT), sold 10,884 shares at $35.58 ($386K) on 2018-02-01, disclosed to the SEC on 2018-02-05.
Open-market sale of $386k AIMT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.95 | 2,300 | $80K | 20.8% |
| 2 | $35.58 | 4,292 | $153K | 39.6% |
| 3 | $35.58 | 4,292 | $153K | 39.6% |
| Total | $35.45 avg | 10,884 | $386K | 100% |
| Filing → |
| AIMT | SELL | 2017-12-28 | $381K | — | Filing → |
| AIMT | SELL | 2017-09-11 | $675K | — | Filing → |
| AIMT | SELL | 2017-07-17 | $320K | — | Filing → |